ResearchMoz

Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2014-02-04
No. Of Pages » 206
   
 The life sciences BPO market comprises services offered by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies.  Pharmaceutical companies are now forming long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for...
Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019)
2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)

Chapter 3 Global Life Sciences BPO Market Dynamics
3.1 Introduction
3.1.1 Drivers
3.1.1.1 Rising cost of R&D and decline in productivity
3.1.1.2 Patent expirations to boost CMO industry growth
3.1.1.3 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions
3.1.1.4 Restructuring of pharmaceutical production
3.1.2 Restraints
3.1.2.1 Data safety concerns
3.1.2.2 Stringent and varied regulatory approval processes in different countries
3.1.2.3 Unforeseen Costs has marred the growth of CRO industry
3.1.3 Opportunities
3.1.3.1 Biologics
3.1.3.2 Emerging markets
3.2 Value Chain Analysis
3.2.1 People Skills and Challenges for Life Sciences BPO Services:
3.2.2 Pharmaceutical Outsourcing
3.2.3 Contract Research Outsourcing Market:
3.2.4 Value Chain Analysis: Contract Research Outsourcing Market
3.2.5 Contract Research Outsourcing Services (%), 2012
3.2.5.1 Contract Research Outsourcing Services (%), 2012
3.2.6 Pharmacovigilance
3.2.6.1 Value Chain Analysis: Pharmacovigilance
3.2.7 Biostatistics
3.2.7.1 Value Chain Analysis: Biostatistics
3.2.8 Risk-based Monitoring
3.2.8.1 Value Chain Analysis: Risk based Monitoring
3.2.9 Study Design and Protocol Development
3.2.9.1 Value Chain Analysis: Study Design and Protocol Development
3.2.10 Medical Writing
3.2.10.1 Value Chain Analysis: Medical Writing
3.2.11 Clinical Data Management
3.2.11.1 Value Chain Analysis: Clinical Data Management
3.2.12 Site Management
3.2.12.1 Value Chain Analysis: Site Management
3.2.13 Regulatory Services
3.2.13.1 Value Chain Analysis: Regulatory Services
3.3 Porter’s Five Force Analysis: Global Life sciences BPO Market
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography
3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe
3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography

Chapter 4 Global Life Sciences BPO Market, by Segments
4.1 Overview
4.2 Pharmaceutical Outsourcing
4.2.1 Contract Manufacturing Outsourcing
4.2.1.1 Active Pharmaceutical Ingredients (API) Manufacturing
4.2.1.1.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
4.2.1.2 Final Dosage Form (FDF) Manufacturing
4.2.1.2.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
4.2.1.3 Packaging
4.2.1.3.1 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
4.2.2 Contract Research Outsourcing
4.2.2.1 Drug Discovery
4.2.2.1.1 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.2 Pre-Clinical Studies
4.2.2.2.1 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.3 Early Phase Clinical Research Services (Phase I / IIa)
4.2.2.3.1 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.4 Phase IIb / IIIa
4.2.2.4.1 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.5 Phase IIIb / IV (Peri/Post Approval Phase / Post Marketing Surveillance)
4.2.2.5.1 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.6 Medical Writing
4.2.2.6.1 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.7 Pharmacovigilance
4.2.2.7.1 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.8 Clinical Data Management
4.2.2.8.1 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.9 Regulatory Services
4.2.2.9.1 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.10 Clinical Monitoring
4.2.2.10.1 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.11 Biostatistics
4.2.2.11.1 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.12 Protocol Development
4.2.2.12.1 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
4.2.2.13 Site Management
4.2.2.13.1 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)

Chapter 5 Global Life Sciences BPO Market, by Geography
5.1 Overview
5.1.1 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
5.1.2 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.2 Germany
5.3.2.1 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.2.2 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.2.3 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.3.2 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2-019 (USD Billion)
5.3.3.3 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.4 France
5.3.4.1 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.4.2 France Contract Manufacturing Outsourcing Service Market, 2011 – 2019 (USD Million)
5.3.4.3 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.5 Italy
5.3.5.1 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.5.2 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.5.3 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.6 Spain
5.3.6.1 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.6.2 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.6.3 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.7 Switzerland
5.3.7.1 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.7.2 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.7.3 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.8 Rest of Europe (ROE)
5.3.8.1 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.3.8.2 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
5.3.8.3 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
5.5 RoW
5.5.1 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

Chapter 6 Global Life Sciences BPO Market Share Analysis
6.1 Market Share Analysis by Key Players of Global CRO Market
6.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%)
6.2 Market Share Analysis by Key Players of Global CMO Market
6.2.1 Global CMO Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Success Strategies
7.1.1 Expand Market into Emerging Countries
7.1.2 Ensure Data Confidentiality and Regulatory Compliance
7.1.3 Timely Entry in the Market
7.1.4 Offer a Wide Range of Research and Manufacturing Services
7.1.5 Developing Strategic Alliances and Partnerships With Pharmaceutical and Biotechnology Companies
7.1.6 Risk Management

Chapter 8 Company Profiles
8.1 Accenture, Plc
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.4.1 Mergers and acquisitions
8.1.5 Recent Developments
8.2 Boehringer Ingelheim GmbH
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.4.1 Research And Development For Medical Innovation
8.2.5 Recent Developments
8.3 Catalent Pharma Solutions, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.4.1 Geographical expansion of business
8.3.4.2 Diversification of product portfolio
8.3.5 Recent Developments
8.4 Charles River Laboratories International, Inc. (CRL)
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.4.1 Expansion of services offered
8.4.4.2 New product launches and Innovation
8.4.4.3 Strategic acquisitions
8.4.5 Recent Developments
8.5 Cognizant Technology Solutions
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.4.1 Expansion of geographical footprint
8.5.4.2 Expansion product portfolio
8.5.4.3 Highly-skilled manpower
8.5.4.4 Strategic acquisitions
8.5.5 Recent Developments
8.6 Covance, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.4.1 New product development and innovation
8.6.4.2 Agreements and collaborations
8.6.4.3 Strategic acquisitions
8.6.4.4 Geographical expansion of business
8.6.5 Recent Developments
8.7 DSM
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.4.1 Strategic acquisitions
8.7.5 Recent Developments
8.8 Fareva
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Business Strategies
8.8.3.1 Extensive product portfolio
8.8.3.2 Safety environment for staff
8.8.3.3 Commitment to quality
8.8.4 Recent Developments
8.9 ICON, Plc
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.4.1 Business expansion in APAC region
8.9.4.2 Expansion of services offered
8.9.5 Recent Developments
8.10 Infosys
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.4.1 Extensive product portfolio
8.10.4.2 Geographical expansion of business
8.10.5 Recent Developments
8.11 International Business Machines Corporation
8.11.1 Company overview
8.11.2 Financial overview
8.11.3 Product Portfolio
8.11.4 Business strategies
8.11.4.1 Focus on increasing facilities for predictive analytics
8.11.4.2 Geographic Expansion
8.11.5 Recent developments
8.12 Lonza Group
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.4.1 Investment in emerging economies
8.12.4.2 Mergers and acquisitions
8.12.5 Recent Developments
8.13 Pharmaceutical Product Development, Inc. (PPD, Inc.)
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.4.1 Expanding geographic presence
8.13.4.2 Incorporation of innovative technologies
8.13.4.3 Strategic acquisitions
8.13.4.4 New product launch and innovation
8.13.5 Recent Developments
8.14 Parexel International Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.4.1 Strong presence in Asia and emerging markets
8.14.4.2 Strategic alliances
8.14.4.3 Mergers & Acquisitions
8.14.5 Recent Developments
8.15 Patheon, Inc.
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
8.15.4.1 Strategic acquisitions
8.15.4.2 Geographical expansion of business
8.15.5 Recent Developments
8.16 Piramal Healthcare
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Business Strategies
8.16.4.1 Expansion of services offered
8.16.5 Recent Developments
8.17 PRA International, Inc.
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Business Strategies
8.17.4.1 Mergers and acquisitions
8.17.5 Recent Developments
8.18 Quintiles Transnational Corporation
8.18.1 Company Overview
8.18.2 Financial Overview
8.18.3 Product Portfolio
8.18.4 Business Strategies
8.18.4.1 Expansion of services
8.18.4.2 Acquisitions and partnerships
8.18.4.3 Innovation in services offered
8.18.5 Recent Developments
8.19 Wipro Limited
8.19.1 Company Overview
8.19.2 Financial Overview
8.19.3 Product Portfolio
8.19.4 Business Strategies
8.19.4.1 Geographical Expansion

Chapter 9 List of the Companies
9.1 List of Companies Offering Contract Research Outsourcing Services in North America.
9.3 List of Companies Offering Contract Research Outsourcing Services in Europe.
9.3.1 List of Contract Research Organizations in France
9.3.2 List of Contract Research Organizations in Italy
9.3.4 List of Contract Research Organizations in Germany
9.3.5 List of Contract Research Organizations in Spain
9.3.6 List of Contract Research Organizations in United Kingdom
9.3.7 List of Contract Research Organizations in Switzerland

List of Tables

List of Tables

TABLE 1 Market Snapshot : Life Sciences BPO Market
TABLE 2 Research and Development Spending per New Drug (2012)
TABLE 3 Global Life Sciences BPO Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 4 Global Pharmaceutical Contract Manufacturing Outsourcing (CMO) Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 5 Global Contract Research Outsourcing Market Revenue, By Types, 2011 – 2019 (USD Billion)
TABLE 6 Outsourced Drug Discovery and Development Expenditures, by Types, USD Billion
TABLE 7 Global Life Sciences BPO Market, by Geography, 2011 – 2019 (USD Billion)
TABLE 8 North America Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 9 Europe Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 10 Germany Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 11 Germany Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 12 Germany Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 13 U.K. Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 14 U.K. Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 15 U.K. Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 16 France Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 17 France Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 18 France Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 19 Italy Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 20 Italy Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 21 Italy Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 22 Spain Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 23 Spain Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 24 Spain Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 25 Switzerland Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 26 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 27 Switzerland Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 28 ROE Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 29 ROE Contract Manufacturing Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 30 ROE Contract Research Outsourcing Services Market, 2011 – 2019 (USD Million)
TABLE 31 Asia-Pacific Life Sciences BPO Market, 2011 – 2019 (USD Billion)
TABLE 32 RoW Life Sciences BPO Market, 2011 – 2019 (USD Billion)

List of Figures

List of Figures

FIG. 1 Global Life Sciences BPO Services : Market Segmentation
FIG. 2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion)
FIG. 3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion)
FIG. 5 Global Life Sciences BPO Market: Drivers and Restraints
FIG. 6 Value Chain Analysis: Pharmaceutical Outsourcing
FIG. 7 Value Chain Analysis: Contract Research Outsourcing Market
FIG. 8 Contract Research Outsourcing Services (%), 2012
FIG. 9 Value Chain Analysis: Pharmacovigilance
FIG. 10 Value Chain Analysis: Biostatistics
FIG. 11 Value Chain Analysis: Risk based Monitoring
FIG. 12 Value Chain Analysis: Study Design and Protocol Development
FIG. 13 Value Chain Analysis: Medical Writing
FIG. 14 Value Chain Analysis: Clinical Data Management
FIG. 15 Value Chain Analysis: Site Management
FIG. 16 Value Chain Analysis: Regulatory Services
FIG. 17 Porter’s Five Force Analysis: Global Life sciences BPO Market
FIG. 18 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography
FIG. 19 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012
FIG. 20 Pharmaceutical Contract Manufacturing Outsourcing, Flow of Services
FIG. 21 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 22 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 23 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
FIG. 24 Pharmaceutical Contract Research Outsourcing, Flow of Services
FIG. 25 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 26 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 27 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 28 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 29 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 30 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 31 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 32 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 33 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 34 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 35 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 36 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 37 Global Contract Site Management Services Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 38 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %)
FIG. 39 Global CRO: Market Share, by Key Players, 2012 (%)
FIG. 40 Global CMO: Market Share, by Key Players, 2012 (%)
FIG. 41 Accenture, Plc.: Annual Revenue (USD Billion) 2010 – 2012
FIG. 42 Boehringer Ingelheim GmbH: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 43 Catalent Pharma Solutions, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 44 Charles River Laboratories International, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 45 Cognizant Technology Solutions: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 46 COVANCE, Inc.: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 47 DSM: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 48 ICON, PLC: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 49 Infosys: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 50 IBM Corporation: Annual Revenue (USD Billion) 2010 – 2012
FIG. 51 Lonza Group: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 52 Parexel International Corporation: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 53 Patheon, Inc.: Annual Sales Revenue, USD Million (2010– 2012)
FIG. 54 Piramal Healthcare: Annual Sales Revenue, USD Million (2010 – 2012)
FIG. 55 Quintiles Transnational Corporation: Annual Sales Revenue, USD Billion (2010– 2012)
FIG. 56 Wipro Limited: Annual Revenue (USD Million) 2010 – 2012

Upcoming Reports:

Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
By - Transparency Market Research
Apheresis, also called as hemapheresis and pheresis is a procedure which involves withdrawal of blood from a donor and separation and retention of its components such as plasma, platelets, leukocytes, and others. Thereafter, the remaining components are transfused back into the donor.  Thus therapeutic apheresis is a procedure of separation of blood into its components and also includes removal of abnormal components. The overall apheresis market is classified from the perspective of donor apheresis and therapeutic apheresis. Increase in health awareness,...
AFP Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Alpha-fetoprotein (AFP) is the most widely found plasma protein in human fetus.  The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4.  It is a major plasma protein which is produced during fetal development in yolk sac and the liver.  AFP is a glycoprotein which is found in monomeric, dimeric and trimeric forms. The protein is normally made by immature liver cells in the fetus therefore; infants have higher levels of AFP, which falls to normal adult level by the end of first year.  Usually, low level of AFP protein is...
Greece: market of vulcanized rubber seals
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the vulcanized rubber seals market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the vulcanized rubber seals market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Open to Hiring Malaysia Airlines Retrenched Employees : AirAsia CEO
Sep 11, 2014  
After reports that Malaysia Airlines will be letting go nearly 6,000 of its staff, chief executive officer of low-cost carrier AirAsia Tan Sri Tony Fernandes has said that he is open to hiring MAS ex-employees as part of its own workforce.  Fernandes said that he welcomes the MAS overhaul and the transition will be a good move for the AirAsia group as well as Malaysia Airlines....
Statoil Expands Natural Gas in Bakken
Sep 11, 2014  
A Norway-based oil company, Statoil known for dealing in natural gas has stamped its strong presence in Bakken, North Dakota. In the last three years, emissions from burning, flaring of methane, natural gas, and hydrogen sulphide related with oil production have risen tremendously. Statoil operates in the effort to expand the technology to power equipment with natural gas that would otherwise...
Apple Watch - The Latest Product Launched By Apple Inc
Sep 11, 2014  
The sale of large screen phones may witness a boost due to the additional feature of mobile payment service that has been included in Apple Inc’s latest iPhone. This could restore the market share of Apple Inc that was lost to Google Inc’s Android segment. Soon after the launch of the Apple Watch and iPhone 6, the shares of Apple rose by almost 1.3% on Wednesday. This also...
China and Russia to Hike Reciprocal Investments
Sep 10, 2014  
In a joint effort to develop high-speed rail, energy, telecommunications, housing, infrastructure projects, and mining, China and Russia have both agreed to increase their reciprocal investment. Zhang Gaoli, the Chinese Vice Premier and Igor Shuvalov, the First Deputy Prime Minister of Russia co-chaired the initial meeting of the Investment Cooperation Committee of China-Russia. The...
Asian Stocks Observe Decline amid Fed Anxiety
Sep 10, 2014  
Asian shares observed a steep decline on Wednesday amid fears that the Federal Reserve would increase interest rates earlier than expected, leading the dollar to jump to its 14-months high against major currencies. Some regional tech shares observed a hit after stocks of Apple Inc fell as the initial excitement about the launch of new products evaporated quickly. Japan stock...